Stock BGNE BEIGENE, LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Calendar BeiGene, Ltd.

Equities

BGNE

US07725L1026

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-31 pm EDT 		5-day change 1st Jan Change
148.8 USD -3.50% Intraday chart for BeiGene, Ltd. -2.53% -17.47%
May. 28 BriaCell Announces Clinical Supply Agreement with BeiGene for Bria-OTS First in Human Study MT
May. 28 BriaCell Therapeutics, BeiGene Partner to Test Combination of Companies' Cancer Treatments MT

Chart calendar BeiGene, Ltd.

0897b42d598a4db.DvkAbQ29YFRM09Ap50nxztoqhrQRlcr-sc86fBs7Aao.YJRDPUnbLTNh5pUf3hucvplP_P5f5JWqiYFfMXJ1Us0_knMcW_UUGSOJkQ~7d5b426c60f35a3becdca9b6e250e57e

Upcoming events on BeiGene, Ltd.

2024-06-03 10:00 am American Society of Clinical Oncology Meeting - Abstract No:TPS7087
2024-06-03 10:00 am American Society of Clinical Oncology Meeting - Abstract No:TPS7090
2024-06-03 10:00 am American Society of Clinical Oncology Meeting - Abstract No:7072
2024-06-03 10:00 am American Society of Clinical Oncology Meeting - Abstract No:11158
2024-06-03 10:00 am American Society of Clinical Oncology Meeting - Abstract No:7048
2024-06-12 European Hematology Association Meeting - Abstract No - P1124
2024-06-12 European Hematology Association Meeting - Abstract No - P538
2024-06-12 European Hematology Association Meeting - Abstract No - PB2546
2024-06-12 European Hematology Association Meeting - Abstract No - P698
2024-06-12 European Hematology Association Meeting - Abstract No - P562
2024-06-12 European Hematology Association Meeting - Abstract No - P697
2024-06-12 European Hematology Association Meeting - Abstract No - P898
2024-06-12 European Hematology Association Meeting - Abstract No - PB2540
2024-06-12 European Hematology Association Meeting - Abstract No - P685
2024-06-12 European Hematology Association Meeting - Abstract No - P1834

Past events on BeiGene, Ltd.

2024-06-01 02:30 pm American Society of Clinical Oncology Meeting - Abstract No:3599
2024-06-01 02:30 pm American Society of Clinical Oncology Meeting - Abstract No:4032
2024-06-01 10:00 am American Society of Clinical Oncology Meeting - Abstract No:2610
2024-06-01 10:00 am American Society of Clinical Oncology Meeting - Abstract No:2605
2024-06-01 10:00 am American Society of Clinical Oncology Meeting - Abstract No:2585
2024-05-08 06:00 am Q1 2024 Earnings Release
2024-05-07 Q1 2024 Earnings Call
2024-03-27 Q4 2023 Earnings Release
2024-03-11 10:00 am Leerink Partners Global Biopharma Conference
2024-03-07 Investor Meeting
2024-03-05 09:50 am TD Cowen Health Care Conference
2024-02-25 Q4 2023 Earnings Release
2024-01-08 04:30 pm JPMorgan Healthcare Conference
2023-12-11 09:00 pm American Society of Hematology Meeting - Abstract No - 5155
2023-12-11 09:00 pm American Society of Hematology Meeting - Abstract No - 5137
2023-12-11 09:00 pm American Society of Hematology Meeting - Abstract No - 5163
2023-12-11 09:00 pm American Society of Hematology Meeting - Abstract No - 5143
2023-12-11 09:00 pm American Society of Hematology Meeting - Abstract No - 4401
2023-12-11 07:30 pm American Society of Hematology Meeting - Abstract No - 1011
2023-12-11 09:00 pm American Society of Hematology Meeting - Abstract No - 5144

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD		Released
Forecast
Spread 		428
445
-3.82%		309
337
-8.35%		1 176
1 198
-1.84%		1 416
1 420
-0.32%		2 459
2 414
1.87%
3 239

EBITDA
Million USD		Released
Forecast
Spread 		-941
-685
-37.4%		-1 626
-1 453
-11.9%		-1 392
-1 201
-15.88%		-1 723
-1 678
-2.69%		-1 120
-1 105
-1.38%
-782

EBIT
Million USD		Released
Forecast
Spread 		-960
-752
-27.72%		-1 658
-1 525
-8.69%		-1 439
-1 239
-16.11%		-1 790
-1 751
-2.23%		-1 208
-1 161
-3.99%
-941

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-944
-740
-27.53%		-1 618
-1 480
-9.35%		-1 439
-1 253
-14.77%		-1 961
-1 853
-5.82%		-826
-903
8.51%
-846

Net income
Million USD		Released
Forecast
Spread 		-949
-750
-26.52%		-1 597
-1 467
-8.88%		-1 413
-1 223
-15.55%		-2 004
-1 832
-9.4%		-882
-911
3.23%
-859

EPS
USD		Released
Forecast
Spread 		-15,8
-14,0
-13.18%		-19,1
-17,8
-7.75%		-15,2
-10,0
-52.22%		-19,4
-15,0
-29.66%		-8,45
-8,56
1.3%
-9,02

Announcement Date02/03/2025/02/2125/02/2227/02/2326/02/24-

Quarterly results

Fiscal PeriodDecember 2021 S2 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2022 S2 2023 Q1 2023 Q2 2023 S1 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales
Million USD		Released
Forecast
Spread 		420
386
8.92%		307
260
17.76%		342
311
9.81%		388
377
2.7%		380
388
-2.08%		606
723
-16.13%		448
449
-0.36%		595
515
15.5%		1 043
946
10.32%		781
578
35.12%		634
638
-0.61%		752
682
10.23%
794


828


886


807


973

EBITDA
Million USD		Released
Forecast
Spread


-427
-247
-72.78%		-424
-310
-36.86%		-422
-355
-18.83%		-451
-442
-1.91%


-351
-346
-1.55%





-112
-232
51.55%		-565
-304
-86.18%		-236
-406
41.89%
-293


-327


-185


-312


-111

EBIT
Million USD		Released
Forecast
Spread


-443
-456
2.88%		-439
-397
-10.61%		-438
-391
-12.08%		-469
-472
0.67%		-907
-1 086
16.48%		-371
-373
0.58%		-319
-393
18.97%		-690
-781
11.66%		-134
-345
61.22%		-589
-364
-61.67%		-261
-362
27.71%
-279


-278


-210


-273


-134

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread


-421
-494
14.79%		-558
-446
-24.94%		-551
-377
-46.08%		-431
-457
5.77%		-982
-1 075
8.63%		-337
-374
10.01%		-367
-379
3.17%		-704
-729
3.37%		229
-365
162.87%		-351
-441
20.54%		-243
-309
21.23%
-259


-238


-226


-185


-108

Net income
Million USD		Released
Forecast
Spread 		-1 000
-925
-8.05%		-434
-519
16.3%		-571
-370
-54.36%		-558
-396
-40.84%		-445
-456
2.24%		-998
-1 105
9.67%		-348
-403
13.62%		-381
-381
0.04%		-730
-752
2.92%		215
-376
157.31%		-368
-431
14.81%		-251
-302
16.88%
-256


-235


-222


-185


-108

EPS
USD		Released
Forecast
Spread


-4,24
-5,32
20.35%		-5,56
-4,11
-35.12%		-5,39
-3,85
-40.04%		-4,29
-4,19
-2.47%


-3,34
-3,82
12.45%		-3,64
-3,53
-2.98%


2,01
-3,28
161.25%		-3,48
-4,03
13.68%		-2,41
-2,89
16.52%
-2,45


-2,25


-2,12


-1,81


-1,05

Announcement Date25/02/2205/05/2204/08/2209/11/2227/02/2327/02/2304/05/2302/08/2302/08/2309/11/2326/02/2408/05/24-----

Upcoming sector events for BeiGene, Ltd.

2024-07-23 VIKING THERAPEUTICS, INC.: Q2 2024 Earnings Release (Projected)
2024-07-24 BIOCON LIMITED: Q1 2025 Earnings Release (Projected)
2024-07-25 01:00 am ARGENX SE: Q2 2024 Earnings Release
2024-07-29 RHYTHM PHARMACEUTICALS, INC.: Q2 2024 Earnings Release (Projected)
2024-07-29 NEUROCRINE BIOSCIENCES, INC.: Q2 2024 Earnings Release (Projected)
2024-07-29 CEREVEL THERAPEUTICS HOLDINGS, INC.: Q2 2024 Earnings Release (Projected)
2024-07-30 CASSAVA SCIENCES, INC.: Q2 2024 Earnings Release (Projected)
2024-07-30 SPRINGWORKS THERAPEUTICS, INC.: Q2 2024 Earnings Release (Projected)
2024-07-30 XENCOR, INC.: Q2 2024 Earnings Release (Projected)
2024-07-30 SAREPTA THERAPEUTICS, INC.: Q2 2024 Earnings Release (Projected)
More events

Past sector events for BeiGene, Ltd.

2024-05-17 07:00 am AUTOLUS THERAPEUTICS PLC: Q1 2024 Earnings Release
2024-05-16 07:46 am BIOCON LIMITED: Q4 2024 Earnings Release
2024-05-16 01:00 am ZEALAND PHARMA A/S: Q1 2024 Earnings Release
2024-05-15 LIGACHEM BIOSCIENCES INC.: Q1 2024 Earnings Release
2024-05-15 08:05 am THIRD HARMONIC BIO, INC.: Q1 2024 Earnings Release
2024-05-15 07:00 am CABALETTA BIO, INC.: Q1 2024 Earnings Release
2024-05-14 TAIMED BIOLOGICS INC.: Q1 2024 Earnings Release
2024-05-14 04:05 pm ENLIVEN THERAPEUTICS, INC.: Q1 2024 Earnings Release
2024-05-14 04:00 pm ARCUTIS BIOTHERAPEUTICS, INC.: Q1 2024 Earnings Release
2024-05-14 08:00 am IMMUNOME, INC.: Q1 2024 Earnings Release

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. BGNE Stock
  4. Calendar BeiGene, Ltd.